{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:57:00Z","timestamp":1774565820161,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.dld.2014.10.018","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T19:52:49Z","timestamp":1416253969000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study"],"prefix":"10.1016","volume":"47","author":[{"given":"Wolfgang","family":"Kreisel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Deibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limas","family":"Kupcinskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Sumskiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Appenrodt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Neagu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"R\u00f6ssle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Zipprich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Caca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Ferlitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Dilger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Mohrbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Greinwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2014.10.018_bib0005","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/hep.22273","article-title":"Portal hypertension and variceal bleeding \u2013 unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference","volume":"47","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D\u2019Amico","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0030","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2003.11.046","article-title":"Nitric oxide in gastrointestinal health and disease","volume":"126","author":"Shah","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0035","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.10.018_bib0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1478-3231.2005.01163.x","article-title":"Portal hypertension: from pathophysiology to clinical practice","volume":"25","author":"Laleman","year":"2005","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2014.10.018_bib0045","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.22203","article-title":"Vascular biology and pathobiology of the liver: report of a single-topic symposium","volume":"47","author":"Iwakiri","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0050","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/MCG.0b013e318150d3b5","article-title":"Hemodynamics in the isolated cirrhotic liver","volume":"41","author":"Zipprich","year":"2007","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0055","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.23222","article-title":"Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis","volume":"50","author":"Trebicka","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0060","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.febslet.2006.02.080","article-title":"Hepatic guanylate cyclase activity is decreased in a model of cirrhosis: a quantitative cytochemistry study","volume":"580","author":"Davies","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/j.dld.2014.10.018_bib0065","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jhep.2006.01.032","article-title":"Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers","volume":"44","author":"Loureiro-Silva","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1016\/j.dld.2014.10.018_bib0075","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ajg.2009.661","article-title":"NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study","volume":"105","author":"Berzigotti","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/gast.2002.35385","article-title":"Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate","volume":"123","author":"Lui","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0090","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/j.gastro.2009.05.049","article-title":"Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence","volume":"137","author":"Kumar","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0095","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2014.10.018_bib0100","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Shattuck Lecture Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2014.10.018_bib0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.ju.0000164463.19239.19","article-title":"Chapter 1: The management of erectile dysfunction: an AUA update","volume":"174","author":"Montague","year":"2005","journal-title":"Journal of Urology"},{"key":"10.1016\/j.dld.2014.10.018_bib0110","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2014.10.018_bib0115","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/dmd.107.020099","article-title":"The contributions of cytochromes P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors sildenafil, udenafil, and vardenafil","volume":"36","author":"Ku","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.dld.2014.10.018_bib0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/hep.20070","article-title":"The hepatic venous pressure gradient: remixed and revisited","volume":"39","author":"Huet","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1478-3231.2004.00892.x","article-title":"Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients","volume":"24","author":"Colle","year":"2004","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2014.10.018_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-230X-9-69","article-title":"Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver","volume":"9","author":"Halverscheid","year":"2009","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2036.2006.02735.x","article-title":"Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver \u2013 results of a pilot study","volume":"23","author":"Deibert","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2014.10.018_bib0140","first-page":"132","article-title":"Inhibitors of phsophodiesterase-5 \u2013 a novel therapy of portal hypertension","author":"Deibert","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1752-1947-1-46","article-title":"Phosphodiesterase 5 inhibitors lower both portal and pulmonary pressure in portopulmonary hypertension: a case report","volume":"1","author":"Bremer","year":"2007","journal-title":"Journal of Medical Case Reports"},{"key":"10.1016\/j.dld.2014.10.018_bib0150","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1872-034X.2008.00388.x","article-title":"Acute administration of sildenafil enhances hepatic cyclic guanosine monophosphate production and reduces hepatic sinusoid resistance in cirrhotic patients","volume":"38","author":"Lee","year":"2008","journal-title":"Hepatology Research"},{"key":"10.1016\/j.dld.2014.10.018_bib0155","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.3748\/wjg.14.6208","article-title":"Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis","volume":"14","author":"Clemmesen","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0160","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cgh.2010.01.017","article-title":"Sildenafil has no effect on portal pressure but lowers arterial pressure in patients with compensated cirrhosis","volume":"8","author":"Tandon","year":"2010","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0165","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3748\/wjg.v18.i11.1166","article-title":"Treatment of portal hypertension","volume":"18","author":"Bari","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.018_bib0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2009.04.015","article-title":"Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension","volume":"51","author":"La Mura","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MEG.0b013e32832ca06b","article-title":"Acute and chronic hemodynamic changes after propranolol in patients with cirrhosis under primary and secondary prophylaxis of variceal bleeding: a pilot study","volume":"22","author":"de Madaria","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0185","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1517\/14656566.2012.693162","article-title":"Chronic PDE-5 inhibition in patients with erectile dysfunction \u2013 a treatment approach using tadalafil once-daily","volume":"13","author":"Porst","year":"2012","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.dld.2014.10.018_bib0190","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.10-0969","article-title":"Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study","volume":"140","author":"Rubin","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.dld.2014.10.018_bib0195","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2012.05.004","article-title":"Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study","volume":"60","author":"Oudiz","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.dld.2014.10.018_bib0200","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI70731","article-title":"PDE5 inhibitor efficacy is estrogen dependent in female heart disease","volume":"124","author":"Sasaki","year":"2014","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.dld.2014.10.018_bib0205","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0210","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hep.23852","article-title":"Beta-blockers in cirrhosis: friend and foe","volume":"52","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.10.018_bib0215","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814007634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814007634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T03:48:39Z","timestamp":1717559319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865814007634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1590865814007634"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2014.10.018","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2014.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}